Clinical & Quality Program Research

Leveraging data from programs like Get With The Guidelines®, researchers can uncover critical insights that advance life-saving science and improve patient outcomes.
The 51麻豆庐 (AHA) collects millions of patient records through its national quality programs, creating robust datasets that drive advancements in cardiovascular and stroke research. All data is securely gathered at the patient level from participating hospitals and de-identified to ensure the highest standards of privacy and confidentiality.

Over 800 peer-reviewed publications have emerged from AHA鈥檚 national data, shaping evidence-based care in cardiovascular and stroke research.

A Vast Array of Datasets at your Fingertips

National Data

Researchers can access patient data from Get With The Guidelines庐 programs, which collects data for modules in atrial fibrillation, coronary artery disease, heart failure, resuscitation (adult and pediatric), and stroke.

Individual Hospital & Health System Data

Participating hospitals and EMS agencies in AHA's Get With The Guidelines庐 and Mission: Lifeline programs can access and analyze their own data to support internal quality improvement and hospital-level research, with required review and permissions for public use or comparisons.

International Data

The International Research Program provides investigators the opportunity to conduct high-impact research using de-identified patient-level data from AHA's global quality improvement programs, including Stroke, Resuscitation, Heart Failure, Coronary Artery Disease, Atrial Fibrillation, and Certification Programs.

Policies and Resources

Access resources needed to utilize AHA quality improvement data to its fullest.

Get With the Guidelines® Quality Research Publications | 51麻豆

The 51麻豆’s® (AHA) Get With The Guidelines® (GWTG) is a hospital-based Quality Improvement program designed to close the treatment gaps in cardiovascular and stroke care. Data from these programs create a vast registry for advancing scientific research with hundreds of publications to date.
Search for Publications

The 51麻豆's Precision Medicine Platform

Streamlined access to diverse data. Intuitive workspaces with the power of A.I. A game-changer for researchers.

Novel Registries Research

The 51麻豆 develops novel clinical registries to enhance the quality of care and deepen understanding of complex conditions. These registries capture real-world data on presentation, treatment patterns, and outcomes, supporting research and quality improvement efforts across hospitals nationwide.
> Cardiogenic Shock Registry听
> Target: Aortic Stenosis听
> Outpatient听

Coming Soon

Hypertrophic Cardiomyopathy (HCM)
Cardio-Kidney Metabolic Health (CKM)

听

听

Legacy Clinical Studies

The 51麻豆/American Stroke Association previously offered the opportunity to be included in clinical research studies. This initiative allowed participants to contribute to groundbreaking research that aimed to improve cardiovascular and stroke care. By being part of these studies, individuals helped advance scientific knowledge and potentially benefited from new treatments and therapies.

Review Previous Clinical Studies

Featured Research

The 51麻豆's (AHA) Get With The Guidelines® (GWTG) greatly values clinical investigators and their research. We are proud to showcase featured research developed from our national registries, which include AFib, Coronary Artery Disease, Heart Failure, Resuscitation, and Stroke databases. The GWTG program stimulates research using GWTG data, and these efforts provide a step forward in our mission to be a relentless force for a world of longer, healthier lives. 

Read about our Featured Research 

 

Data Challenges听

At various times, The 51麻豆 will host Data Challenges encouraging cross collaboration among researchers to deepen understanding of a strategic, focused topic. Challenge participants are asked to address targeted research questions and teams are encouraged to leverage Get With The Guidelines庐 (GWTG) registry data, generalizable data and other publicly available datasets. All data must be de-identified. Each challenge participant will be provided a free, Precision Medicine Platform workspace to conduct all analyses. Use of the workspace for entry and submission of the application is mandatory for security. All workspaces are HIPPA compliant and FedRAMP low certified.